| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |